The first FDA-approved teriparatide alternative for Forteo®*

What is Teriparatide Injection?

Teriparatide Injection is a medication designed to assist in building new bone, and is comprised of protein similar to one naturally produced by the body. It has also been shown to help increase bone strength.

Teriparatide Injection helps to grow healthy bones by increasing bone mineral density and bone strength, which may prevent fractures.

Proven Results

Postmenopausal women with osteoporosis, who were at high risk for fracture, experienced significantly increased bone mineral density in the spine, after taking Teriparatide Injection with calcium and vitamin D. These results were demonstrated at 3 months, and throughout the treatment period.

The risk of new spine fractures was reduced by approximately two thirds. The risk of new fractures in other bones—including the ankle/foot, hip, upper arm, pelvis, ribs, and wrist—was cut in half.

*Forteo is a registered trademark of Eli Lilly and Company, which has no affiliation with Alvogen.

Only proven in postmenopausal women with osteoporosis.

This clinical study involved 1,637 postmenopausal women with osteoporosis, of whom 90% had a spine fracture. 541 women took a daily 20-mcg dose of Teriparatide Injection; 544 took a placebo for a median time of 19 months, and a maximum of 2 years. All women took calcium and vitamin D daily.

Build new bone with Alvogen’s Teriparatide Injection